DOCS Straddle Strategy
DOCS (Doximity, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NYSE.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS (Doximity, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $4.39B, a trailing P/E of 22.05, a beta of 1.35 versus the broader market, a 52-week range of 20.55-76.51, average daily share volume of 3.1M, a public-listing history dating back to 2021, approximately 827 full-time employees. These structural characteristics shape how DOCS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.35 indicates DOCS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a straddle on DOCS?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current DOCS snapshot
As of May 15, 2026, spot at $18.68, ATM IV 56.70%, IV rank 12.07%, expected move 16.26%. The straddle on DOCS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 98-day expiry.
Why this straddle structure on DOCS specifically: DOCS IV at 56.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a DOCS straddle, with a market-implied 1-standard-deviation move of approximately 16.26% (roughly $3.04 on the underlying). The 98-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DOCS expiries trade a higher absolute premium for lower per-day decay. Position sizing on DOCS should anchor to the underlying notional of $18.68 per share and to the trader's directional view on DOCS stock.
DOCS straddle setup
The DOCS straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DOCS near $18.68, the first option leg uses a $18.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DOCS chain at a 98-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DOCS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $18.68 | N/A |
| Buy 1 | Put | $18.68 | N/A |
DOCS straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
DOCS straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on DOCS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on DOCS
Straddles on DOCS are pure-volatility plays that profit from large moves in either direction; traders typically buy DOCS straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
DOCS thesis for this straddle
The market-implied 1-standard-deviation range for DOCS extends from approximately $15.64 on the downside to $21.72 on the upside. A DOCS long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current DOCS IV rank near 12.07% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DOCS at 56.70%. As a Healthcare name, DOCS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DOCS-specific events.
DOCS straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DOCS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DOCS alongside the broader basket even when DOCS-specific fundamentals are unchanged. Always rebuild the position from current DOCS chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on DOCS?
- A straddle on DOCS is the straddle strategy applied to DOCS (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With DOCS stock trading near $18.68, the strikes shown on this page are snapped to the nearest listed DOCS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DOCS straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the DOCS straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 56.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DOCS straddle?
- The breakeven for the DOCS straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DOCS market-implied 1-standard-deviation expected move is approximately 16.26%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on DOCS?
- Straddles on DOCS are pure-volatility plays that profit from large moves in either direction; traders typically buy DOCS straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current DOCS implied volatility affect this straddle?
- DOCS ATM IV is at 56.70% with IV rank near 12.07%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.